Although Harte-Hanks, Inc. HHS is up over 6.1% in the past four weeks, investors may be concerned. After all, HHS is now in overbought territory, at least when looking at its RSI value of 70.7. If that wasn't enough, investors should also note that Harte-Hanks possesses a Zacks Rank #4 (Sell), so if analyst perception is any guide, we could witness a slump in HHS shares before too long.
HARTE-HANKS INC HHS: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
